Project Grant R01AI189680
Award Date 2/9/26
Completion Date 1/31/31
Dollars Obligated $791K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University $433,125 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 21, 2025, for an exploratory research project extending through July 31, 2027. This project grant supports investigation of natural killer (NK) cell-mediated antibody-dependent cellular cytotoxicity (ADCC) enhancement through a novel oral adjuvant combined with the...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University a $605,778 Project Grant effective July 7, 2025, through June 30, 2030, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This award supports fundamental biomedical research investigating the role of ARIADNE RBR E3 ubiquitin protein ligase 2 (ARIH2) in influenza A virus (IAV) replication and pathogenesis within airway epithelial cells....
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University a $354,416 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective February 2, 2026, with a completion date of January 31, 2028. This research initiative investigates novel peroxisome functions in Histoplasma capsulatum pathogenesis, specifically examining how the fungal pathogen exploits macrophage organelles to facilitate...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University a Project Grant of $433,125 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct basic research on influenza A virus (IAV) pathogenesis and acute respiratory distress syndrome (ARDS) mechanisms. The two-year research initiative, awarded July 2, 2025, and extending through June 30, 2027, investigates how the viral PB1-F2 protein...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University a Project Grant of $537,861 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2030. This grant supports the development and advancement of pairwise survival analysis statistical methods for studying infectious disease transmission within households and close-contact groups. The research extends existing...
- Federal Project Grant Award Summary The Ohio State University received a $787,498 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 19, 2026, with a completion date of January 31, 2031. The grant supports fundamental immunology research investigating how STING (Stimulator of Interferon Genes) signaling mechanisms enhance innate immune responses and facilitate phagocyte...
- Federal Grant Award Summary The Ohio State University received a $227,588 Project Grant award from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2027. The award supports research into bioprotein-mediated degradation of HIV-1 Rev protein as a novel therapeutic approach. The project involves developing protein-based proteolysis targeting chimeras (BIOPROTACs) that...
- Federal Project Grant Award Summary The Ohio State University received a $222,098 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 3, 2025, with completion targeted for January 31, 2027. This grant supports research investigating the role of the septin cytoskeleton in plasma membrane (PM) repair mechanisms. The research addresses a significant gap in understanding how...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University $189,057 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project period commencing August 1, 2025 and concluding July 31, 2027. This project grant supports research investigating the efficacy of pre-exposure prophylaxis (PrEP) antiretroviral drugs in blocking Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) transmission...
- Federal Grant Award Summary The Ohio State University received a $758,645 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 2, 2026, with completion targeted for January 31, 2031. This research initiative investigates the mechanisms by which the liver clears gut-derived lipopolysaccharide (LPS) from blood circulation to prevent endotoxemia and associated systemic...